Insight

Mar 26, 2024, 04:50

The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared on X/Twitter:

“Listen to the latest ASCO podcast where Dr. Angela DeMichele, Dr. Lynn Henry, and Dr. Harold Burstein discuss the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer.
Listen here.”

Source: Dana-Farber’s Breast Oncology Center /X

Angela DeMichele ASCO ASCO Guidelines podcast Breast Cancer cancer Dana-Farber Breast Oncology Center endocrine therapy Harold Burstein HR+/HER2- breast cancer Lynn Henry metastatic breast cancer OncoDaily Oncology targeted therapy

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity